Routine cardiovascular risk assessments and timely implementation of GLP-1RAs and SGLT2 inhibitors are also essential for reducing the adverse CVEs in patients with NAFLD and type 2 diabetes
Penetration reached a record 30.2%, exceeding 28% for the first time, while YOY transaction volume grew by 13.5%
Takhshid MA, et al
Recalls & Warnings July 28, 2022 FDA Warns Three Manufacturers of Sanitizer for Manufacturing and Misbranding Violations Between July 8 and July 21, the FDA issued warning letters to three companies selling hand sanitizer products that violate Current Good Manufacturing Practices (cGMP), are adulterated and misbranded, and for refusal to allow the agency to access and copy company records
Impact of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) on Food Content During Esophagogastroduodenoscopy (EGD) Ann
If your symptoms become severe, bothersome, or last for longer than a few weeks, you should talk with your doctor
